Xencor, Inc.
Bispecific antibodies that bind to CD38 and CD3
Last updated:
Abstract:
The invention provides novel heterodimeric proteins including heterodimeric antibodies.
Status:
Grant
Type:
Utility
Filling date:
17 Oct 2017
Issue date:
8 Dec 2020